Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Comparison of baseline patient factors between 3 frailty transition states (n = 122)Total (n-122)Regressed (n = 39)Unchanged (n = 44)Progressed(n = 39)DemographicsAge75.4 (7.1)77.1 (6.9)73.9 (7.2)75.3 (7.1)Gender (Male %)40.138.536.446.2Race (Chinese %)94.392.397.792.3Education years7.1 (5.0)6.6 (4.8)7.3 (4.5)7.3 (5.8)CDR global0.9 (0.5)0.9 (0.5)0.9 (0.4)0.9 (0.5)CDR Sum of boxes4.0 (3.0)4.6 (2.9)3.8 (2.7)3.6 (3.4)CMMSE20.0 (6.5)19.2 (5.3)20.9 (5.2)20.1 (6.5)Medical comorbiditiesHT (%)65.674.454.669.2DM (%)29.538.520.530.8Hyperlipidemia (%)70.566.770.574.4IHD (%)21.323.125.015.4Smoker/ex-heavy smoker (%)15.512.818.215.3 *AF (%)3.35.10.05.1PVD (%)0.82.600Multimorbidity score2.1 (1.2)2.2 (1.2)1.9 (1.2)2.1 (1.3)MDD (%)2.52.62.32.6Neurodegeneration and wm scoresAPOE statusE2/e20.82.600E2/e30.20.10.10E2/e41.62.62.30E3/e347.543.647.751.3E3/e432.833.331.833.3E4/e44.97.74.62.6MTA score1.2 (1.1)1.2 (1.1)1.3 (1.0)1.2 (1.1)ARWMC score4.9 (4.2)5.0 (5.2)5.5 (4.1)4.2 (3.1)Function, behaviour and burden scoresADL97.8 (5.8)95.9 (9.0)99.0 (2.8)98.5 (3.1)*a iADL15.7 (13.7)13.7 (5.9)16.5 (5.1)16.8 (4.6) *a, b NPI total severity2.1 (1.7)2.2 (1.8)2.3 (1.9)1.7 (1.3)NPI CG distress3.6 (5.3)3.9 (6.0)4.4 (5.5)2.2 (3.9)Zarit total22.6 (16.1)21.6 (12.6)24.1 (19.8)21.9 (14.7)FAI total22.9 (8.1)21.0 (7.9)24.9 (8.7)22.7 (7.1)Nutrition, lean mass and functional performanceMNA total11.8 (1.4)11.6 (1.2)118 (1.6)12.2 (1.4)Grip strength19.5 (7.5)18.1 (7.3)20.6 (8.0)19.8 (7.1)SPPB total8.7 (2.3)8.6 (2.1)9.2 (2.2)8.2 (2.6)Lean mass measurement6.6 (8.2)8.0 (13.9)5.9 (0.9)5.8 (0.9)TreatmentDonepezil44.542.141.950.0Galantamine0000Rivastigmine4.25.34.72.6Memantine22.734.225.67.9 *Socioeconomic and lifestyle factorsExpenses More than enough34.460.144.463.0 Fair37.533.344.429.6 Not enough28.13.011.17.4Lifestyle factors (%)Daily Activities 1 + h33.339.422.240.7 20-59 min31.327.338.925.9 < 20 min19.818.222.218.5 none15.615.216.714.8Vegetable and fruit intake (%)Daily83.378.886.185.2< Daily16.721.213.914.8Fish intake (%)Daily41.730.355.637.0< Daily58.369.744.463.0 (p = 0.08)Social support factors (%)Neighbours None22.927.322.218.5 1-449.045.452.848.2 5-914.612.111.122.2 10+13.515.213.911.1Laboratory investigationsTotal chol4.9 (1.1)5.1 (1.1)4.8 (1.2)5.0 (0.9)LDL2.8 (0.9)3.0 (1.0)2.6 (0.9)2.8 (0.8)HDL1.6 (0.7)1.6 (0.5)1.6 (0.7)1.7 (0.7) *TG1.3 (0.7)1.2 (0.7)1.4 (0.9)1.2 (0.5) *Vit D level30.3 (11.9)29.5 (13.1)29.6 (10.6)32.1 (12.1) Abbreviations: CDR clinical dementia rating, CMMSE Chinese mini mental state examination (range 0 to 28), HT hypertension, DM diabetes mellitus, IHD ischaemic heart disease, AF atrial fibrillation, PVD peripheral vascular disease, BMI body-mass index, ETOH ethanol, MDD diagnostic statistical manual definition of major depressive disorder, MTA medial temporal atrophy, ARWMC age-related white matter changes, ADL activities of daily living (range 0 to 100), CG caregiver; activities of daily living (range 0 to 23), NPI neuropsychiatric inventory, FAI frenchay activity index, MNA mini-nutritional assessment, SPPB short physical performance battery, LDL low-density lipoprotein, HDL high-density lipoprotein, TG triglyceride, Vit D Vitamin D*p < 0.05 between the 3 frailty transition subgroups (ANOVA with Bonferroni correction for parametric and Kruskal-Wallis test for nonparametric continuous variables; Chi-square test for categorical variables) adifferences between frailty regressed and unchanged state bdifferences between frailty regressed and progressed state
Source: Comparison of patient factors between 3 frailty transition status (Table 2). View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Single-blind reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This is a prospective cohort study of mild cognitive impairment (MCI) and mild-moderate Alzheimer’s disease (AD) community-dwelling subjects.
Source: Abstract.
A single blinded assessor (Y.R) measured the four components of grip strength, timed walk, unintentional weight loss (>3 kg) and fatigue to yield a modified Fried criteria [], which is better operationalized in the clinical setting.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Prospective longitudinal study of frailty transitions in a community-dwelling cohort of older adults with cognitive impairment
Cohort study · BMC Geriatrics · 2015
Original publication title
Prospective longitudinal study of frailty transitions in a community-dwelling cohort of older adults with cognitive impairment
© Chong et al. 2015
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Frailty and cognitive impairment are seemingly distinct syndromes, but have a shared vulnerability to stress in older adults, resulting in poorer outcomes. Although there has been recent interest in cognitive frailty, frailty transitions in relation to cognitive deterioration in older adults with cognitive impairment have not yet been well studied. We thus aim to study frailty transitions and change in cognitive status over 1-year follow-up among subjects with cognitive impairment attending a tertiary Memory Clinic.
Source: BackgroundAbstract: What methods does the paper describe?
This is a prospective cohort study of mild cognitive impairment (MCI) and mild-moderate Alzheimer’s disease (AD) community-dwelling subjects. We obtained data on clinical measures, muscle mass and physical performance measures. Cognitive status was measured using Chinese Mini-Mental State Examination (CMMSE) and Clinical Dementia Rating-Sum of Boxes (CDR-SB) scores. We measured gait speed, hand grip strength, exhaustion and weight loss at baseline, 6 and 12 months to classify subjects according to the modified Fried criteria (involving strength, gait speed, body composition and fatigue) into non-frail (<2 frail categories) and frail categories (≥2 frail categories).
Frailty transitions between baseline and 12-months were assessed. We performed random effects statistical modelling to ascertain baseline predictors of longitudinal frailty scores for all subjects and within MCI subgroup.
Source: MethodsAbstract: Results
Among 122 subjects comprising 41 MCI, 67 mild and 14 moderate AD, 43.9, 35.8 and 57.1 % were frail at baseline respectively. Frailty status regressed in 32.0 %, remained unchanged in 36.0 %, and progressed in 32.0 % at 12 months. Random effects modelling on whole group showed longitudinal CDR-SB scores (coeff 0.09, 95 % confidence interval (CI) 0.03 to 0.15) and age (coeff 0.04, 95 % CI 0.02 to 0.07) to be significantly associated with longitudinal frailty score. Among MCI subjects, only female gender (coeff 1.28, 95 % CI 0.21 to 2.36) was associated with longitudinal frailty score, while mild-moderate AD subjects showed similar results as those of the whole group.
Source: ResultsAbstract: Conclusions
This is the first study to show longitudinal frailty state transitions in cognitively-impaired older adults. Frailty transitions appear to be independent of progression in cognitive status in earliest stages of cognitive impairment, while mild-moderate AD subjects showed associations with age and cognitive deterioration. The potential for cognitive frailty as a separate therapeutic entity for future physical frailty prevention requires further research with a suitably powered study over a longer follow-up period.
Source: ConclusionsAuthors’ abstract
Background
Frailty and cognitive impairment are seemingly distinct syndromes, but have a shared vulnerability to stress in older adults, resulting in poorer outcomes. Although there has been recent interest in cognitive frailty, frailty transitions in relation to cognitive deterioration in older adults with cognitive impairment have not yet been well studied. We thus aim to study frailty transitions and change in cognitive status over 1-year follow-up among subjects with cognitive impairment attending a tertiary Memory Clinic.
Methods
This is a prospective cohort study of mild cognitive impairment (MCI) and mild-moderate Alzheimer’s disease (AD) community-dwelling subjects. We obtained data on clinical measures, muscle mass and physical performance measures. Cognitive status was measured using Chinese Mini-Mental State Examination (CMMSE) and Clinical Dementia Rating-Sum of Boxes (CDR-SB) scores. We measured gait speed, hand grip strength, exhaustion and weight loss at baseline, 6 and 12 months to classify subjects according to the modified Fried criteria (involving strength, gait speed, body composition and fatigue) into non-frail (<2 frail categories) and frail categories (≥2 frail categories).
Frailty transitions between baseline and 12-months were assessed. We performed random effects statistical modelling to ascertain baseline predictors of longitudinal frailty scores for all subjects and within MCI subgroup.
Results
Among 122 subjects comprising 41 MCI, 67 mild and 14 moderate AD, 43.9, 35.8 and 57.1 % were frail at baseline respectively. Frailty status regressed in 32.0 %, remained unchanged in 36.0 %, and progressed in 32.0 % at 12 months. Random effects modelling on whole group showed longitudinal CDR-SB scores (coeff 0.09, 95 % confidence interval (CI) 0.03 to 0.15) and age (coeff 0.04, 95 % CI 0.02 to 0.07) to be significantly associated with longitudinal frailty score. Among MCI subjects, only female gender (coeff 1.28, 95 % CI 0.21 to 2.36) was associated with longitudinal frailty score, while mild-moderate AD subjects showed similar results as those of the whole group.
Conclusions
This is the first study to show longitudinal frailty state transitions in cognitively-impaired older adults. Frailty transitions appear to be independent of progression in cognitive status in earliest stages of cognitive impairment, while mild-moderate AD subjects showed associations with age and cognitive deterioration. The potential for cognitive frailty as a separate therapeutic entity for future physical frailty prevention requires further research with a suitably powered study over a longer follow-up period.
Publication and source details
Original title: Prospective longitudinal study of frailty transitions in a community-dwelling cohort of older adults with cognitive impairment
Mei Sian Chong; Laura Tay; Mark Chan; Wee Shiong Lim; Ruijing Ye; Eng King Tan; Yew Yoong Ding
BMC Geriatrics · 2015
© Chong et al. 2015https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.http://dx.doi.org/10.13039/100007419Lee Foundation2009National Healthcare Group Clinician Scientist Career Scheme1200213001Tay LauraRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T20:13:47.671199+00:00
DOI: 10.1186/s12877-015-0174-1 · PMC4696312